Abstract
AbstractThis study aimed to analyze the prevalence, sociobehavioral factors and clinical-laboratory consequences of late presentation among people living with HIV (PLHIV) in the Brazilian Amazon region. In total, 402 HIV + individuals treated at reference units in Belém city (Pará, Brazil) between 2018 and 2019 were evaluated. Late presentation was defined as a first-collection LTCD4+ count below 350 cells/µL. Sociodemographic, behavioral and clinical data were obtained from questionnaires or medical records. Th1, Th2 and Th17 cytokine profiles were evaluated by flow cytometry. Longitudinal data on viral load, T lymphocytes, and antiretroviral therapy administration were obtained from control and logistic databases. Approximately 52.73% of the participants were late presenters and sought medical care 7–12 + months after their primary HIV diagnosis. Sociobehavioral factors associated with late presentation included illicit drug use for more than 5 years, polyamory, no alcohol consumption, homosexuality, and sexual inactiveness after HIV diagnosis. Clinically, late presentation was associated with coinfection rate; polysymptomatology; high IFN-ɣ, IL-6 and IL-10 levels; nonresponse to antiretroviral therapy; and virological failure- and tuberculosis coinfection-motivated changes to therapy. In summary, the prevalence of late presentation in Pará in the Brazilian Amazon region is high. Delays in seeking specialized care after a primary HIV diagnosis cause medium/long-term changes in the life expectancy and health of PLHIV.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação Amazônia Paraense de Amparo à Pesquisa
Instituto Nacional de Ciência e Tecnologia em Viroses Emergentes e Reemergentes - INCT-VER
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Publisher
Springer Science and Business Media LLC
Reference80 articles.
1. Lange M, Buimovici-Klein E, Kornfeld H, Quilop MT, Pahwa S, Reddy M, Wong P, Phillips L, Kiyasu J, Moriarty M, Wechter S, Cooper LZ, Grieco MH. Prospective observations of viral and immunologic abnormalities in homosexual males. Ann N Y Acad Sci. 1984;437:350–63. https://doi.org/10.1111/j.1749-6632.1984.tb37155.x.
2. Kelly DA, Hallett RJ, Saeed A, Morgan G, Levinsky RJ, Strobel S. Prolonged survival and late presentation of vertically transmitted HIV infection in childhood. Lancet. 1987;1(8536):806–7. https://doi.org/10.1016/s0140-6736(87)92830-3.
3. Gillieatt SJ, Mallal SA, French MA, Dawkins RL. Epidemiology of late presentation of HIV infection in Western Australia. Med J Aust. 1992;157(2):117–8.
4. Poznansky MC, Coker R, Skinner C, Hill A, Bailey S, Whitaker L, Renton A, Weber J. HIV positive patients first presenting with an AIDS defining illness: characteristics and survival. BMJ. 1995;311(6998):156–8. https://doi.org/10.1136/bmj.311.6998.156. Erratum in: BMJ 1995;311(7001):356.
5. DeMaria A Jr, Kunches L, Mayer K, Cohen C, Epstein P, Werner B, Day J, DeCristofaro J, Landers S, Tang Y, Coady W. Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working Group. J Hum Virol. 2000 Jul-Aug;3(4):182–92.